Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REFILE-UPDATE 2-Strong sterling knocks FTSE 100 despite trade lull

Thu, 05th Sep 2019 09:29

(Reinstates dropped word 'said' in para 7)

* FTSE 100 down 0.6%, FTSE 250 up 0.2%

* Exporter stocks fall as pound surges

* CYBG tanks on mid-caps

* Online retailer Boohoo jumps after forecast upgrade

* Industrials up on upbeat forecast from European peers

By Muvija M and Indranil Sarkar

Sept 5 (Reuters) - London's FTSE 100 slipped on Thursday as
a surge in sterling pushed exporter stocks lower, missing out on
a global rally led by growing hopes of a resolution to the
U.S.-China trade dispute.

The FTSE 100 slid 0.6%, with multinationals
including spirits company Diageo, pharma giants
AstraZeneca and GlaxoSmithKline slipping about
3% as a strong pound meant the value of their U.S. earnings was
lower.

Sterling recorded its biggest two-day rise in 10 months as
no-deal Brexit worries took a break, after lawmakers voted to
prevent Prime Minister Boris Johnson from taking Britain out of
the European Union without a deal on Oct. 31.

Strength in the local currency lifted the more domestically
focussed mid-cap index by 0.2%, despite a 21% slump in
CYBG to an all-time low. The Yorkshire Bank and Virgin
Money owner said it expected to increase its provision for
legacy payment protection insurance costs.

Stocks trading without dividend entitlement on the day such
as BHP, Glencore and Micro Focus fell
between 1.2%-3%, weighing heavily on the blue-chip index. Micro
Focus is also set to be relegated from the index later this
month.

Meanwhile, indexes on Wall Street and Europe scaled a
one-month high as agreement by China and the United States to
hold high-level trade talks in October spurred hopes that the
trade dispute between the countries would be resolved.

"If one was feeling cynical, Thursday's rally could be used
to illustrate investors' refusal to learn from their past
mistakes, stung time and time again by a pair of superpowers who
never manage to deliver on their trade talk promises," said
Spreadex analyst Connor Campbell.

The FTSE 100 had suffered its only monthly fall this year in
August when trade tensions escalated between the world's largest
economies.

As investors turned to riskier assets on account of renewed
trade hopes and away from safe haven gold, precious metals miner
Fresnillo tumbled nearly 6% and was the steepest faller
on the FTSE 100.

Industrial giants BAE Systems and Rolls-Royce
helped limit the index's fall with gains of 1% each after
French engine maker Safran hiked a profit forecast and
Rafale warplanes maker Dassault Aviation affirmed a
higher net sales target.

Another prominent gainer was turnaround specialist Melrose
which jumped 9% after its first-half profit beat
estimates.

On the mid-cap bourse, specialist media services company
Future Plc surged 10% after upbeat forecast, while
payments solutions provider Network International lost
7.5% as its major shareholder Emirates NBD Bank sold stock at a
discount.

AIM-listed online fashion retailer Boohoo shot up
by 15.1% to a life high after raising its annual revenue growth
forecast and small-cap oil firm EnQuest climbed 7% after
affirming its full-year production view and cutting debt.
(Reporting by Shashwat Awasthi, Muvija M and Indranil Sarkar in
Bengaluru; Editing by Bernard Orr)

More News
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.